+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Gonorrhea (GN): Competitive Landscape - Product Thumbnail Image

Gonorrhea (GN): Competitive Landscape

  • Report
  • September 2024
  • 78 Pages
  • Global
From
Dysmenorrhea: Competitive Landscape - Product Thumbnail Image

Dysmenorrhea: Competitive Landscape

  • Report
  • September 2024
  • 79 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033

  • Report
  • August 2024
  • 49 Pages
  • Global
From
Delirium - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Delirium - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 529 Pages
  • Global
From
Epstein-Barr Virus: Competitive Landscape - Product Thumbnail Image

Epstein-Barr Virus: Competitive Landscape

  • Report
  • August 2024
  • 66 Pages
  • Global
From
Focal Segmental Glomerulosclerosis: Competitive Landscape - Product Thumbnail Image

Focal Segmental Glomerulosclerosis: Competitive Landscape

  • Report
  • August 2024
  • 76 Pages
  • Global
From
Acute coronary syndrome: Competitive Landscape - Product Thumbnail Image

Acute coronary syndrome: Competitive Landscape

  • Report
  • August 2024
  • 79 Pages
  • Global
From
Metachromatic Leukodystrophy (MLD) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Metachromatic Leukodystrophy (MLD) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • July 2024
  • 63 Pages
  • Global
From
Chronic Urticaria Or Hives - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Chronic Urticaria Or Hives - Global Clinical Trials Review, 2024

  • Clinical Trials
  • July 2024
  • 458 Pages
  • Global
From
Migraine: Epidemiology Forecast to 2033 - Product Thumbnail Image

Migraine: Epidemiology Forecast to 2033

  • Report
  • July 2024
  • 48 Pages
  • Global
From
Alcoholic Hepatitis: Competitive Landscape - Product Thumbnail Image

Alcoholic Hepatitis: Competitive Landscape

  • Report
  • July 2024
  • 65 Pages
  • Global
From
Renal Cell Carcinoma (RCC) Epidemiology Analysis and Forecast to 2033 - Product Thumbnail Image

Renal Cell Carcinoma (RCC) Epidemiology Analysis and Forecast to 2033

  • Report
  • July 2024
  • 59 Pages
  • Global
From
Hepatic Encephalopathy: Competitive Landscape - Product Thumbnail Image

Hepatic Encephalopathy: Competitive Landscape

  • Report
  • July 2024
  • 69 Pages
  • Global
From
Primary Sclerosing Cholangitis: Competitive Landscape - Product Thumbnail Image

Primary Sclerosing Cholangitis: Competitive Landscape

  • Report
  • June 2024
  • 65 Pages
  • Global
From
Prurigo Nodularis: Competitive Landscape - Product Thumbnail Image

Prurigo Nodularis: Competitive Landscape

  • Report
  • June 2024
  • 80 Pages
  • Global
From
Substance (Drug) Abuse - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Substance (Drug) Abuse - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 2468 Pages
  • Global
From
Dyslipidemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Dyslipidemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 1761 Pages
  • Global
From
Spinal Muscular Atrophy (SMA) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Spinal Muscular Atrophy (SMA) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 155 Pages
  • Global
From
Zollinger-Ellison Syndrome (Gastrinoma) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Zollinger-Ellison Syndrome (Gastrinoma) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • June 2024
  • 342 Pages
  • Global
From
Chronic Kidney Disease: Epidemiology Forecast to 2033 - Product Thumbnail Image

Chronic Kidney Disease: Epidemiology Forecast to 2033

  • Report
  • June 2024
  • 43 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more